Terms: = Prostate cancer AND ACKR3
3 results:
1. CXCR7 as a novel therapeutic target for advanced prostate cancer.
Gritsina G; Yu J
Oncogene; 2023 Mar; 42(11):785-792. PubMed ID: 36755058
[TBL] [Abstract] [Full Text] [Related]
2. Identification of Potential Key Genes and Pathways in Enzalutamide-Resistant prostate cancer Cell Lines: A Bioinformatics Analysis with Data from the Gene Expression Omnibus (GEO) Database.
Zheng L; Dou X; Ma X; Qu W; Tang X
Biomed Res Int; 2020; 2020():8341097. PubMed ID: 32724813
[TBL] [Abstract] [Full Text] [Related]
3. Expression profile-based screening for critical genes reveals S100A4, ackr3 and CDH1 in docetaxel-resistant prostate cancer cells.
Zhu S; Min Z; Qiao X; Chen S; Yang J; Zhang X; Liu X; Ran W; Lv R; Lin Y; Wang J
Aging (Albany NY); 2019 Dec; 11(24):12754-12772. PubMed ID: 31895690
[TBL] [Abstract] [Full Text] [Related]